Group items tagged

Microsoft has posted an awesome new concept video with some ubercool new interfaces that could be here in five to ten years, estimates Kurt DelBene, President, Microsoft Office Division. That sounds a bit conservative. "All of the ideas in the video are based on real technology," he said. "Some of the capabilities, such as speech recognition, real time collaboration, and data visualization, already exist today. Others are not yet available in specific products, but represent active research and development happening at Microsoft and other companies." "Other companies" … hmm, some of the concepts look a bit like Nokia's visionary Morph concept tech  (see the video at the bottom of this post and our 2010 news item).

Thomas J. Johnson, the creator of the modern Schmidt-Cassegrain telescope and the founder of Celestron, died early this morning (March 13, 2012), according to Celestron president and CEO Joe Lupica. Johnson was 89. He ranked among the most important figures shaping the last half century of amateur astronomy.

A new study suggests that cost-effective galactic radio transmissions would be at higher frequencies than SETI projects traditionally monitor, and ET's attempts to make contact would be only few and far between. "If ET was building cost-effective beacons, would our searches have detected them? The answer turns out to be no," says James Benford, president of the company Microwave Sciences in Lafayette, California.

It is a truth universally acknowledged that education is the key to economic success. Everyone knows that the jobs of the future will require ever higher levels of skill. That's why, in an appearance Friday with former Florida Gov. Jeb Bush, President Obama declared that "If we want more good news on the jobs front then we've got to make more investments in education." But what everyone knows is wrong.

A 36-year-old man has received the world's first synthetic trachea, made from a synthetic scaffold seeded with his own stem cells, in an operation at the Karolinska University Hospital in Stockholm, Sweden. Professor Paolo Macchiarini of Karolinska University Hospital and Karolinska Institutet led an international team, including professor Alexander Seifalian from University College London, who designed and built the nanocomposite tracheal scaffold, and Harvard Bioscience, which produced a specifically designed bioreactor used to seed the scaffold with the patient´s own stem cells. The cells were grown on the scaffold inside the bioreactor for two days before transplantation to the patient. Because the cells used to regenerate the trachea were the patient's own, there has been no rejection of the transplant and the patient is not taking immunosuppressive drugs. "The big conceptual breakthrough is that we can move from transplanting organs to manufacturing them for patients," says David Green, the president of Harvard Bioscience in Holliston, Massachusetts. Transplantations of tissue-engineered windpipes with synthetic scaffolds in combination with the patient's own stem cells as a standard procedure means that patients will not have to wait for a suitable donor organ. Patients could benefit from earlier surgery and have a greater chance of cure. This would be of especially great value for children, since the availability of donor tracheas is much lower than for adult patients.